• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 20th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
The Saint-Gobain logo is seen on top of the company headquarters building at the La Defense business district in Courbevoie, outside Paris, France, May 14, 2018.  Charles Platiau
The Saint-Gobain logo is seen on top of the company headquarters building at the La Defense business district in Courbevoie, outside Paris, France, May 14, 2018. Charles Platiau
Home
Litigation

France's Saint-Gobain, others hit with price-fixing claims in US court

November 30th, 2023 | 20:03 PM Litigation 3

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Novonesis expects results from weight-loss drug supplement study in 2027
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump
Ping An Insurance's first-half profit jumps 36% on asset management boost
Australia passes law to levy tech giants that fail to pay for local news
By Mike Scarcella

French building materials giant Saint-Gobain (SGOB.PA) and other major European makers of construction chemicals are facing a new lawsuit in Philadelphia federal court over claims they conspired to fix the prices of key ingredients that are added to cement, concrete and mortar.

The prospective class-action lawsuit was filed on Wednesday by a general contractor supply company in Jamestown, New York, accusing Saint-Gobain, Swiss firm Sika (SIKA.S), Germany's Master Builders Solutions and other defendants of conspiring to artificially inflate prices.

The lawsuit from M&D Peterson LLC comes after the European Commission, working with British and Turkish competition authorities, announced in October surprise inspections of companies in the construction chemicals sector.

Sika, Saint-Gobain and Master Builders were targets of the probe, the lawsuit said.

A Saint-Gobain spokesperson pointed to a statement that said the group was cooperating and that "at this stage we see no reason to believe there will be an impact" on the company.

Representatives for Sika and Master Builders did not immediately respond to requests for comment.

Sika has said the company was not aware of "any culpability" but was cooperating with the authorities.

Attorneys from the plaintiffs' firm Hausfeld, which filed the lawsuit, on Thursday had no immediate comment.

Investigations announced by the European Commission and other enforcement bodies can drive private civil litigation in the United States.

A group of major European and U.S. flavor and fragrance producers were hit with a wave of private lawsuits in U.S. federal court over the summer after Swiss and other antitrust authorities revealed a price-fixing cartel investigation earlier this year.

In the cement, concrete and mortar case, the key ingredients at the center of the lawsuit come in liquid or powder form and are used to produce qualities in the finished product, according to the lawsuit.

The complaint said Sika and the other defendants "manufacture and sell the vast majority of [the ingredients] sold in the United States."

"Defendants have been secure in their knowledge that their competitors — the other defendants — will not undercut them on price," the lawsuit said.

The lawsuit seeks triple damages under U.S. antitrust law and an injunction that would bar the alleged conspiracy to set prices.

The case is M&D Peterson LLC v. Sika AG et al, U.S. District Court for the Eastern District of Pennsylvania, No. 2:23-cv-04711.

For plaintiff: Jeannine Kenney, Nathaniel Giddings, Scott Martin, Michael Lehmann and others from Hausfeld; Arthur Bailey of Rupp Pfalzgraf

For defendants: No appearances yet

Read more:

St Gobain see no financial impact from EU construction chemicals cartel probe

Sika shares slide after EU raids companies over price-fixing suspicions

EU raids construction chemicals sector over competition concerns

Jumpstart your morning with top legal news delivered straight to your inbox from The Daily Docket.

  • Topic
  • CONSTRUCTION
  • ANTITRUST/LAWSUIT
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Novonesis expects results from weight-loss drug supplement study in 2027

Related Posts

Litigation
August 20th, 2026

Novonesis expects results from weight-loss drug supplement study in 2027

Litigation
August 20th, 2026

Celon Pharma's generic semaglutide drug matches Ozempic in early study, ...

Litigation
August 20th, 2026

Ping An Insurance's first-half profit jumps 36% on asset management boos...

Litigation
August 20th, 2026

Australia passes law to levy tech giants that fail to pay for local news

Litigation
August 20th, 2026

SK Hynix to pay 60% of employee bonuses in company stock under prelimina...

Litigation
August 20th, 2026

CK Hutchison seeks $1.5 billion from Panama in treaty dispute arbitratio...

The Wire
Aug 20th 5 h ago
Business

AI productivity gains may not curb inflation, IMF's Tenreyr...

Aug 20th 5 h ago
Aerospace & Defense

Latvia says drone in its airspace on August 14 was Ukrainia...

Aug 20th 5 h ago
India

Indian central bank deputy urges banks to improve retail fo...

Aug 20th 5 h ago
Baseball

Guardians chase elusive home series win in matchup vs. Gian...

Aug 20th 5 h ago
Americas

Brazil to keep fiscal framework, spending restraint under n...

TRENDING ON FINANCETIME
Aug 20th, 2026 Asia Pacific

Bangladesh elects ruling party veteran Alamgir as president

Aug 20th, 2026 Africa

AFRICA-FX-Ghana's currency back under pressure, Uganda's on front foot

Aug 20th, 2026 Soccer

How would a vote of no confidence work to oust FIFA president Infantino?

Aug 20th, 2026 Europe

Romania destroys marine drone near Neptun Deep gas project, minister says

Aug 20th, 2026 Baseball

Sal Stewart, Reds strive for edge in finale of 5-game series vs. Cards

Markets-Sectors
TELECOMMUNICATIONS SERVICES +0.03%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT